Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)

Clinical trial NCT06902844 · RECRUITING

Trial details

NCT number: NCT06902844
Sponsor: Tongji Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)

Start date: 2025-04-05
Primary completion: 2027-10-31
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.